California State Teachers Retirement System (CalSTRS)’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-75,995
Closed -$507K 3087
2023
Q3
$507K Sell
75,995
-9,901
-12% -$82.3K ﹤0.01% 2190
2023
Q2
$778K Sell
85,896
-2,064
-2% -$18.2K ﹤0.01% 2073
2023
Q1
$639K Sell
87,960
-365
-0.4% -$2.71K ﹤0.01% 2174
2022
Q4
$644K Buy
88,325
+897
+1% +$6.66K ﹤0.01% 2212
2022
Q3
$676K Buy
87,428
+20,998
+32% +$178K ﹤0.01% 2168
2022
Q2
$452K Buy
66,430
+31,844
+92% +$244K ﹤0.01% 2445
2022
Q1
$276K Buy
34,586
+4,035
+13% +$25.6K ﹤0.01% 2586
2021
Q4
$171K Buy
+30,551
New +$229K ﹤0.01% 2840

Other funds holding PNT

California State Teachers Retirement System (CalSTRS)'s PNT Position: Q4 2023 in Review

California State Teachers Retirement System (CalSTRS) sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 75,995 shares — an estimated $507K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in PNT in Q4 2021 and held it in 8 quarters. The position peaked at $778K in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

  • California State Teachers Retirement System (CalSTRS) reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 75,995 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $507K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in POINT Biopharma Global Inc. Common Stock in Q4 2021 and held it in 8 quarters.
  • California State Teachers Retirement System (CalSTRS)'s POINT Biopharma Global Inc. Common Stock position peaked at $778K in Q2 2023.
  • 1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q4 2023, filed 13 Feb 2024.